Contrasting Sotera Health (NASDAQ:SHC) & Fortrea (NASDAQ:FTRE)

Fortrea (NASDAQ:FTRE – Get Free Report) and Sotera Health (NASDAQ:SHC – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Profitability

This table compares Fortrea and Sotera Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fortrea -3.18% 10.72% 2.17%
Sotera Health 13.44% 40.12% 7.55%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Fortrea and Sotera Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortrea 1 5 6 0 2.42
Sotera Health 0 3 8 0 2.73

Fortrea presently has a consensus price target of $22.10, indicating a potential upside of 10.83%. Sotera Health has a consensus price target of $21.50, indicating a potential upside of 22.47%. Given Sotera Health’s stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Fortrea.

Insider and Institutional Ownership

91.0% of Sotera Health shares are owned by institutional investors. 0.7% of Fortrea shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Fortrea has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500.

Earnings and Valuation

This table compares Fortrea and Sotera Health”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fortrea $2.72 billion 0.70 -$986.20 million ($0.91) -21.91
Sotera Health $1.16 billion 4.31 $77.94 million $0.57 30.80

Sotera Health has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Summary

Sotera Health beats Fortrea on 12 of the 14 factors compared between the two stocks.

About Fortrea

(Get Free Report)

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

About Sotera Health

(Get Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter.